In the present study, we identified serine peptidase inhibitor Kazal type 1 (SPINK1) as a protein that meets the following 2 criteria: it secreted from hypoxic cancer cells into plasma and induced radioresistance of cancers. The gene discussed is SPINK1; the disease is cancer.